Ground broken on Sanofi/Transgene's new manufacturing unit
This article was originally published in Scrip
Executive Summary
Sanofi and Transgene have broken ground on their manufacturing plant dedicated to the production of viral vectors. The companies announced their collaboration to build the unit in March 2013 (scripintelligence.com, 25 March 2013).